Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Several viruses in the Arenaviridae family cause severe life-threatening hemorrhagic fever syndromes, which are considered neglected tropical diseases in endemic areas of Africa and South America. Ribavirin, the only licensed antiviral indicated for use has limited efficacy when treating advanced ca...
Main Authors: | Mendenhall, Michelle, Russell, Andrew, Smee, Donald F., Hall, Jeffery O., Skirpstunas, Ramona, Furuta, Yousuke, Gowen, Brian B. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191123/ |
Similar Items
-
Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
by: Yamada, Kentaro, et al.
Published: (2016) -
Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
by: Gowen, Brian B., et al.
Published: (2013) -
Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
by: Oestereich, Lisa, et al.
Published: (2014) -
Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
by: Caroline, Amy L., et al.
Published: (2014) -
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
by: Tani, Hideki, et al.
Published: (2016)